Pioneered by Italian ophthalmologist Benedetto Strampelli in the early 1960s, tooth-in-eye surgery is intended to minimize ...

Roche’s Susvimo, a refillable eye implant for diabetic macular edema, provides continuous delivery of ranibizumab, showing sustained vision improvements with fewer treatments than standard eye ...

This new FDA approval for the implant is slightly different from the previous indication, as the new injection uses an ocular implant to impart 100 mg/mL intravitreally. 1 The implant can be ...

After years of blindness, Brent Chapman underwent tooth-in-eye surgery in Canada, where a tooth is used to implant a lens in ...

Seven months after the FDA signed off on a reintroduction of Roche’s eye implant Susvimo, the U.S. regulator has broadened its label as a treatment for diabetic macular edema (DME), which is the ...

Pune: A 61-year-old Kolhapur farmer, who had lost one eye, narrowly escaped losing his other eye after a devastating farm accident, thanks to the timely intervention of a city doctor who provided ...

It returned to the market in the middle of last year – after updates to the implant and refill needle – as an alternative to AMD therapies that require regular injections into the eye ...

Susvimo is indicated for intravitreal use via the Susvimo ocular implant. The implant is surgically inserted during a one-time outpatient procedure and provides continuous release of ranibizumab ...

Neuralink's brain implant chip, 'the Link,' connects human brains to computers, aiding those with paralysis in movement control. Neuralink’s brain implant chip is a bold step toward merging ...

A Canadian woman regained her vision after a groundbreaking procedure at Vancouver's Mount Saint Joseph Hospital, where part ...

About Susvimo® (ranibizumab injection) 100 mg/mL for intravitreal use via ocular implant Susvimo® (ranibizumab injection) 100 mg/mL for intravitreal use via ocular implant is a refillable ...